ctrl K

Watchlist Price Alert

Evaxion Biotech A/S (EVAX)

NASDAQ: EVAX · Real-Time Price · USD

2.11

-0.29 (-12.08%)

At close: Jun 17, 2025, 3:59 PM

2.05

-2.74%

Pre-market: Jun 18, 2025, 04:27 AM EDT

Evaxion Biotech A/S Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	3.34M	73K	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	112.00	571.32K	343.45K	105.72K	80.98K	73.93K
Gross Profit	3.34M	72.89K	-571.32K	-343.45K	-105.72K	-80.98K	-73.93K
Operating Income	-14.73M	-22.2M	-25.26M	-25.83M	-16.57M	-10.86M	-5.63M
Interest Income	254K	154K	2.83M	2.04M	216K	9K	2K
Pretax Income	-11.36M	-22.91M	-23.94M	-24.71M	-16.57M	-12.02M	-6.27M
Net Income	-10.57M	-22.13M	-23.17M	-24.53M	-15.02M	-11.2M	-5.54M
Selling & General & Admin	7.32M	10.35M	8.21M	6.25M	5.67M	2.63M	1.88M
Research & Development	10.46M	11.92M	17.06M	19.58M	10.9M	8.22M	3.73M
Other Expenses	302K	n/a	n/a	n/a	n/a	16K	15K
Operating Expenses	18.08M	22.25M	25.26M	25.83M	16.57M	10.86M	5.63M
Interest Expense	962K	897K	1.51M	915K	223K	1.22M	698K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	18.08M	22.27M	25.26M	25.83M	16.57M	10.86M	5.63M
Income Tax Expense	-788K	-791.22K	-772K	-178K	-1.56M	-825K	-735K
Shares Outstanding (Basic)	1.07M	683.39K	590.97K	487.33K	404.97K	404.97K	479.97K
Shares Outstanding (Diluted)	1.07M	683.39K	590.97K	487.33K	404.97K	404.97K	479.97K
EPS (Basic)	-10	-32.44	-39.2	-50.32	-37.08	-27.64	-11.52
EPS (Diluted)	-10	-32.44	-39.2	-50.32	-37.08	-27.64	-11.52
EBITDA	-9.77M	-21.4M	-22.58M	-24.17M	-16.46M	-11.9M	-6.18M
EBIT	-10.39M	-22.02M	-23.16M	-24.51M	-16.66M	-11.98M	-6.25M
Depreciation & Amortization	607.02K	615.95K	571.32K	343.45K	105.72K	80.98K	73.93K